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A B S T R A C T
Titanium-based materials are widely employed by the biomedical industry in orthopedic and dental implants.
However, when placed into the human body, these materials are highly susceptible to degradation processes,
such as corrosion, wear, and tribocorrosion. As a consequence, metallic ions or particles (debris) may be re-
leased, and although several studies have been conducted in recent years to better understand the effects of their
exposure to living cells, a consensual opinion has not yet been obtained. In this work, we produced metallic-
based wear particles by tribological tests carried out on Ti-6Al-4V and Ti-15Zr-15Mo alloys. They were pos-
teriorly physicochemically characterized according to their crystal structure, size, morphology, and chemical
composition and compared to Ti-6Al-4V commercially available particles. Finally, adsorbed endotoxins were
removed (by applying a specific thermal treatment) and endotoxin-free particles were used in cell experiments to
evaluate effects of their exposure to human osteoblasts (MG-63 and HOb), namely cell viability/metabolism,
proinflammatory cytokine production (IL-6 and PGE2), and susceptibility to internalization processes. Our re-
sults indicate that tribologically-obtained wear particles exhibit fundamental differences in terms of size
(smaller) and morphology (irregular shapes and rough surfaces) when compared to the commercial ones.
Consequently, both Ti-6Al-4V and Ti-15Zr-15Mo particles were able to induce more pronounced effects on cell
viability (decrease) and cytokine production (increase) than did Ti-6Al-4V commercial particles. Furthermore,
both types of wear particles penetrated osteoblast membranes and were internalized by the cells. Influences on
cytokine production by endotoxins were also demonstrated.
1. Introduction
Among the metallic implant biomaterials (Chen and Thouas, 2015),
the mechanical properties, biocompatibility, and corrosion resistance of
titanium (Ti) and its alloys make them particularly favorable for use in
dental (Cordeiro and Barão, 2017) and orthopedic (Geetha et al., 2009)
implants. Industrial production of Ti-based biomaterials is dominated
by commercially pure titanium (cp-Ti) and a Ti alloy with 6 wt% of
aluminum (Al) and 4wt% of vanadium (V), denoted hereafter as Ti-6Al-
4V (Chen and Thouas, 2015; Cordeiro and Barão, 2017). More recently,
to address the reported long-term health effects associated with Al and
V, new titanium alloys (Gepreel and Niinomi, 2013; Niinomi et al.,
2012), such as Ti-15Zr-15Mo with 15 wt% each of zirconium (Zr) and
molybdenum (Mo), have been proposed (Correa et al., 2016, 2015;
2014; Xavier et al., 2017).
Many of the beneficial characteristics of Ti-based materials are as-
sociated with both passivation and protection provided by the surface
film formed on these materials in contact with biological fluids (Sundell
et al., 2017; Wang et al., 2016). Nevertheless, over time any implant
material is subject to degradation through wear, corrosion, and their
synergistic effect known as tribocorrosion (Mathew et al., 2009;
Ponthiaux et al., 2012). Consequently, metallic ions and/or particles
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may be released from the implant surface and affect the surrounding
living cells and tissues. However, the associated short and long-term
biological effects are still unclear (Alves et al., 2013, 2015;
Amanatullah et al., 2016; Cvijović-Alagić et al., 2016; Ribeiro et al.,
2016; Vasconcelos et al., 2016).
Common effects associated with the accumulation of wear particles
in living organisms include: local fibrosis/necrosis, characterized by a
greyish appearance of the tissues surrounding an implant, known as
metallosis (C. A. Oliveria et al., 2015; Watters et al., 2010); excessive
activation of macrophages; increased production of proinflammatory
cytokines, namely the tumor necrosis factor α (TNF- α), interleukins 1,
1α, 1β, 6, and 10 (IL-1, IL-a, IL-1β, IL-6, and IL-10) and prostaglandin
E2 (PGE2) (Bitar and Parvizi, 2015; Hallab and Jacobs, 2017;
Landgraeber et al., 2014; Sukur et al., 2016; Veronesi et al., 2017) by
immune-system cells, bone cells (osteoblasts), and connective tissue
cells (fibroblasts), which can activate/stimulate osteoclasts, ultimately
leading to the bone resorption and implant loosening by osteolysis
(Bitar and Parvizi, 2015; Veronesi et al., 2017); and a pathology known
as “particle disease” (Sukur et al., 2016; Vasconcelos et al., 2016).
The specific physicochemical characteristics of the metallic wear
particles, e. g., crystallinity, size, morphology, and chemical composi-
tion, play an important role in determining their biological effects
(Konttinen and Pajarinen, 2013; Li et al., 2014). For retrieved or si-
mulated wear particles, the current literature is primarily focused on
two popular orthopedic implant materials: cobalt-chromium alloys (Co-
Cr) and ultra-high-molecular-weight polyethylene (UHMWPE)
(Afolaranmi et al., 2012; Hongtao et al., 2011; Horev-Azaria et al.,
2011; Kwon et al., 2009; Papageorgiou et al., 2008; Pourzal et al., 2011;
Sansone et al., 2013; Wang et al., 2010). In contrast, rather than using
retrieved or simulated wear particles, most studies of Ti-based implant
materials rely on model cp-Ti particles with controlled size and mor-
phology and examine their effects on immune-system cells (macro-
phages and/or monocytes), connective-tissue cells (fibroblasts), or
mesenchymal stem cells (Haleem-Smith et al., 2012; Lee et al., 2012;
Mostardi et al., 2010; Soto-Alvaredo et al., 2014; Wu et al., 2008).
Here, we produced simulated-wear particles of Ti-6Al-4V and Ti-
15Zr-15Mo from tribological tests under physiological electrolyte con-
ditions. These wear particles were characterized and compared to
commercial Ti-6Al-4V particles for crystal structure, chemical compo-
sition, size, and morphology. To avoid false positives in the subsequent
cell viability and cytokine assays due to the presence of surface-ad-
sorbed endotoxins (residual lipopolysaccharides (LPS) from Gram-ne-
gative bacteria, which are not considered in most particle studies) (Li
and Boraschi, 2016; Magalhães et al., 2007), all the particles were
thermally treated under conditions sufficient to inactivate any adherent
endotoxins (Magalhães et al., 2007; McIntyre and Reinin, 2009). Two
different cell lines of human osteoblasts were then exposed in vitro to
the endotoxin-free Ti-based particles to investigate their internalization
as well as any effects on cell viability and production of proin-
flammatory cytokines interleukin 6 (IL-6) and prostaglandin 2 (PGE2).
2. Materials and methods
2.1. Materials
Commercial Ti-6Al-4V discs (20mm in diameter and 3.5mm in
thickness, from VSMPO TIRUS, USA) and in-house-processed arc-
melted Ti-15Zr-15Mo ingot cuts (irregular shapes and 3.5mm in
thickness, from Anelasticity and Biomaterials Laboratory,
UNESP—Bauru, Brazil) were used as sources of simulated-wear parti-
cles. The crystallographic structures of both bulk materials were char-
acterized by X-ray diffraction (XRD) using a diffractometer (D/MAX
2100 PC, Rigaku) with Cu-Kα source operated at a voltage of 40 kV and
current of 20mA, divergence slit of 1°, receiving slit of 0.3mm, a nickel
filter, and a 10–100° XRD angular scan with 0.02° steps at 1.6 s per step.
The microstructure and chemical composition of the bulk alloys were
characterized by scanning electron microscopy (SEM) in a commercial
microscope (EVO LS15, Carl Zeiss) equipped with an energy-dispersive
spectroscopy (EDS) detector (Inca ACT-X, Oxford). Commercial Ti-6Al-
4V particles were purchased from Electro-Optical Systems, USA.
2.2. Production and characterization of wear particles
Wear particles of Ti-6Al-4V or Ti-15Zr-15Mo were produced by
tribological experiments in a pin-on-disc tribometer operated in re-
ciprocating mode, using an alumina ball (10mm in diameter) as a
counter-body. Before tests, all samples were gradually polished down to
#1200 grade SiC paper, cleaned in an ultrasonic bath, alternating
deionized water and ethanol as cleaning solutions, etched 30 s in a 1:1:1
(by volume) mixture of phosphoric acid (H3PO4), hydrochloric acid
(HCl), and deionized water (H2O), and cleaned again in an ultrasonic
bath. A fresh phosphate-buffered saline (PBS) solution was prepared for
each experiment by dissolving sodium chloride (NaCl, 8 g/L), po-
tassium chloride (KCl, 0.2 g/L), disodium phosphate (Na2HPO4, 1.44 g/
L), and monopotassium phosphate (KH2PO4, 0.24 g/L) in deionized
water. Using the fresh PBS as an electrolyte simulating physiological
fluid, several multi-hour tribological experiments were performed
under the following conditions: a normal load of 3 N, frequency of 1 Hz,
and electrolyte temperature of 37 ± 2 °C (body temperature).
At the end of each tribological experiment, wear particles of Ti-6Al-
4V or Ti-15Zr-15Mo were collected, stored in falcon tubes, separated
from electrolyte by centrifugation and dried at room temperature. The
size, morphology, and chemical composition of the collected wear
particles and the commercial Ti-6Al-4V particles were characterized by
SEM in a commercial microscope (Quanta 650, FEI) equipped with an
energy-dispersive spectroscopy (EDS) detector (Inca ACT-X, Oxford).
The crystal structure of the particles was characterized by electron
diffraction in a transmission electron microscope (TEM, JEM-2100,
JEOL) operated at an accelerating voltage of 200 kV.
2.3. Endotoxin removal
To remove/inactivate any adherent endotoxins, thermal treatments
were applied to the commercial Ti-6Al-4V particles and the wear par-
ticles of Ti-6Al-4V and Ti-15Zr-15Mo in a thermogravimetric and dif-
ferential scanning calorimeter (TGA/DSC) system (1 STAR, Mettler-
Toledo) equipped with a gas analysis system (OmniStar GSD320,
Pfeiffer Vacuum). Following the literature recommendation of treat-
ment at 250 °C for> 30min (Magalhães et al., 2007; McIntyre and
Reinin, 2009), the particles were treated at 250 °C for 45min, under Ar
gas flow (50mL/min) to avoid thermal oxidation. The heat-treated
particles were evaluated for the presence of any residual active en-
dotoxin by Limulus amoebocyte lysate (LAL) gel-clot assays with sen-
sitivities of 0.06 EU/mL and 0.125 EU/mL (ToxinSensor Single Test
Kits, GenScript), according to the manufacturer recommendations.
Briefly, LAL assays provide - qualitative and semi-quantitative in-
formation regarding the presence of endotoxins in a sample by the re-
action with a specific enzyme (amoebocyte) from the Limulus
Polyphemus horseshoe crab's blood (tested samples are mixed with en-
zyme aliquots at the bottom of endotoxin-free test tubes). When the
amount of adsorbed endotoxins in a sample is higher than the test
sensitivity, a positive reaction occurs and a firm clot is observed at the
bottom of the test tubes, remaining in place when they are inverted
upside down.
To perform the LAL tests, positive controls (C1 and C2) were pre-
pared from the total content reconstitution of the Control Standard for
Endotoxin vial (CSE, GenScript, 15 EU) in 1mL of endotoxin-free water
(Lonza EU/mL < 0.005), followed by vortex mixing for 15min for
complete homogenization. Then, the initial positive control (15 EU/mL)
was serially diluted for final concentrations of C1= 0.250 EU/mL and
C2=0.125 EU/mL. Finally, after heat treatments, all particle samples
were dispersed in endotoxin-free PBS (EU/mL < 0.01) at
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concentrations of 500 and 100 μg/mL (ten-fold higher than those pos-
teriorly used in cell experiments). All dispersions were used for the LAL
gel-clot assays that were compared to the positive controls C1 and C2,
regarding the clotting reaction.
2.4. Cell-viability assays
Osteoblast-like cells (MG63, ATCC) and primary normal human
osteoblasts (HOb, Sigma-Aldrich) were cultured at 37 °C in a 5% CO2
atmosphere, respectively, in α-MEM and Growth Media (both from
Sigma-Aldrich) cell-culture media, supplemented with 10% ultra-low-
endotoxin fetal bovine serum (FBS, Biowest), 1% of penicillin/strep-
tomycin, and 1% of amphotericin B.
For cell-viability assays, 3× 10³ cells were cultured in the wells of a
96-well plate and incubated for 24 h at 37 °C in a 5% CO2 atmosphere.
Taking advantage of its accelerated proliferation rate, an initial dose-
response survey was performed with MG63 cell line for particle con-
centrations of 100, 50, 10, 1, 0.5, and 0.1 μg/mL and experimental
periods of 1, 2, 3, and 7 days. Based on the results obtained for
MG63 cell line and values reported in the literature for possible in vivo
metal concentrations in patients with a titanium prosthesis (Hallab
et al., 2001), particle concentrations of 50 and 10 μg/mL and experi-
mental periods of 3 and 7 days were chosen for the cell-viability assays
for HOb cell line.
For both MG63 and HOb cell lines, all cell-viability assays were
conducted in triplicate and the untreated control group consisted of
cells cultured only in the supplemented cell culture medium, as speci-
fied above. Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) reduction staining test. After
the specified incubation periods, 100 μL of MTT (0.5mg/mL) was
added to each well and the culture plates were incubated at 37 °C for
4 h. Then, MTT solution was removed, and 50 μL of dimethyl sulfoxide
(DMSO) was added to each well. After 30min, the optical density was
measured at 550 nm in a monochromator-based multi-mode microplate
reader (Synergy H1, Bio-Tek).
2.5. Particle internalization
The possible particle internalization by HOb cells exposed to the
wear particles was investigated by transmission electron microscopy
(TEM). In a well of a 24-well plate, 2× 104 cells/mL were cultured at
37 °C in a 5% CO2 atmosphere and then exposed to 50 μg/mL of wear
particles of Ti-6Al-4V or Ti-15Zr-15Mo for 24 h. The positive control
group consisted of cells cultured only in the supplemented cell culture
medium, as specified before (see 2.4 Cell-viability assays). After ex-
posure to the wear particles, cells were detached from the plates by
trypsinization (0.04% trypsin in 0.25% EDTA solution, 5min) and
centrifuged. The cell pellet was washed in 0.1 M sodium cacodylate
buffer, fixed (2.5% glutaraldehyde, 2 h), and post-fixed (2% osmium
tetroxide, overnight). Dehydration was performed in graded ethanol
solutions and samples were embedded in epoxy resin (EPON, Hexion).
Ultra-thin (100 nm) sections were prepared in a RMC Ultramicrotome
(PowerTome) using a diamond knife and mounted on copper grids.
Finally, grids were contrasted with uranyl acetate and lead citrate for
TEM analysis at an accelerating voltage of 60 kV (EM 10A, Carl Zeiss).
2.6. Pro-inflammatory cytokine assays
The production of IL-6 and PGE2 cytokines by HOb cells after ex-
posure to wear particles of Ti-6Al-4V or Ti-15Zr-15Mo was evaluated
using commercial enzyme-linked immunosorbent assays (ELISA): IL-6
Human ELISA and PGE2 Human ELISA kits, both from Novex. Cell-
culture supernatants of HOb cells (see 2.4 Cell-viability assays) exposed
to wear particles at the chosen concentrations (50 and 10 μg/mL) and
experimental periods (3 and 7 days) were used, according to the
manufacturer protocol. The untreated control group consisted of cells
cultured only in the supplemented cell culture medium, as specified
before (see 2.4 Cell-viability assays). Two additional experimental
groups, exposed to endotoxins at 50 or 100 ng/mL (corresponding to
500 and 1,000 EU/mL) prepared from control standard endotoxin (CSE,
15 EU/mL, GenScript), were included. Assays for each set of conditions
were conducted in triplicate.
Fig. 1. Bulk crystal structure and surface microstructure of Ti alloys used to generate wear particles. XRD wide-angle scans and SEM images are shown for the
commercial Ti-6Al-4V alloy (A and C) and in-house-processed Ti-15Zr-15Mo alloy (B and D).
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2.7. Statistical analysis
Analysis of variance (ANOVA), followed by post-hoc Tukey test in
Origin 7.0 software (OriginLab) was conducted to calculate the differ-
ences within the datasets (n=3) obtained from MTT and ELISA mea-
surements; p-values< 0.05 were considered statistically significant.
3. Results
3.1. Bulk structure and composition of Ti alloys
Before tribological experiments, the crystal structure and chemical
composition of the polished and cleaned bulk samples of Ti alloys were
characterized by XRD, SEM, and EDS (Fig. 1, Table 1).
The EDS analysis confirmed the nominal alloying composition for
both Ti-6Al-4V and Ti-15Zr-15Mo (Table 1). The commercial Ti-6Al-4V
alloy exhibited XRD peaks (Fig. 1A) of hexagonal (α-Ti) crystal struc-
ture (ICDD PDF card 65–6231) with a small contribution from a body-
centered cubic (β-Ti) crystal structure (ICDD PDF card 44–1288), in
agreement with observing β-phase precipitates in an α-Ti matrix by
SEM (Fig. 1C). In contrast, the crystal structure of the in-house-pro-
cessed Ti-15Zr-15Mo alloy is indexed as pure β-Ti (Fig. 1B), and its
surface exhibits a characteristic granular β-phase microstructure in SEM
images (Fig. 1D).
3.2. Physicochemical characterization of Ti-based particles
Morphology, crystal structure, and chemical composition were in-
vestigated for three types of Ti-based particles: wear particles produced
from tribological tests on Ti-6Al-4V and Ti-15Zr-15Mo alloys and
commercial Ti-6Al-4V particles used as a reference material.
According the obtained results, commercial Ti-6Al-4V particles
differ significantly from both types of wear particles. SEM images
(Fig. 2A and B) clearly illustrate that these particles have smooth sur-
faces and an approximately spherical morphology with an average
diameter in the 30–45 μm range (Fig. 3A). Both crystal structure and
composition of these particles are similar to the characteristics of the
commercial bulk Ti-6Al-4V alloy summarized in Fig. 1A and Table 1,
with XRD peaks related to the α-Ti and β- Ti phases (Fig. 4A) and close-
to-nominal composition determined by EDS: 90.1 ± 1.4 wt% of Ti,
5.5 ± 1.9 wt% of Al, and 4.3 ± 1.5 wt% of V.
In contrast to the commercial Ti-6Al-4V particles, the wear particles
of Ti-6Al-4V exhibit rough surfaces and a highly irregular morphology
(Fig. 2C and D) with average sizes in the 2–4 μm range (Fig. 3B). Their
crystal structure determined by electron diffraction (ED) matches that
of the parent material, i.e., the contribution of both α and β-Ti phases
(Fig. 4B). The alloying composition of these wear particles was slightly
Ti-rich compared to the parent material, with 4.3 ± 0.9 wt% of Al and
3.7 ± 1.4 wt% of V (cf. Table 1).
The wear particles of Ti-15Zr-15Mo also exhibit rough surfaces and
a highly irregular morphology (Fig. 2E and F), but with average sizes in
the 0.6–1.5 μm range (Fig. 3C), which is significantly smaller than those
of the Ti-6Al-4V wear particles (cf. Fig. 3B) and commercial Ti-6Al-4V
particles. Compared to the parent material, the Ti-15Zr-15Mo wear
particles follow the same trend as do the Ti-6Al-4V ones, with the ED
pattern indexed as β-Ti crystal structure (Fig. 4C) and similar alloying
composition (13.3 ± 1.4 wt% of Zr and 13.2 ± 1.1 wt% of Mo, cf.
Table 1).
3.3. Producing endotoxin-free particles
Surface contamination by endotoxins is notoriously difficult to
avoid or remove, due in part to the stability of LPS molecules under
conventional autoclave conditions (Li and Boraschi, 2016; Magalhães
et al., 2007). Accordingly, to remove or inactivate any adherent en-
dotoxins, all particles were thermally treated at 250 °C for 45min
(Magalhães et al., 2007; McIntyre and Reinin, 2009). After the thermal
treatment, each of the three particle types (Ti-6Al4V and Ti-15Zr-15Mo
wear particles and commercial Ti-6Al4V particles) was tested at two
concentrations (100 and 500 μg/mL, i.e., ten times higher than the
chosen concentrations for cell viability and cytokine assays) in LAL gel-
clot assays at two sensitivity levels (0.06 and 0.125 EU/mL). Negative
results, i.e., no clots for dispersed particle samples in PBS were observed
(when compared to the positive controls, which exhibited clot forma-
tion when C1 and C2 endotoxin controls were used) for all the LAL gel-
clot assays, confirming that all particles, at concentrations used in the
subsequent cell experiments, could be designated as endotoxin-free.
3.4. Effects of exposure to Ti-based particles on cell viability
Taking advantage of their high proliferation rate, MG-63 cells were
used to test (via MTT assays) the effects on cell viability of exposure to
all three of the particle types across a broad range of particle con-
centrations and experimental periods (Fig. 5). Compared to the un-
treated controls, exposure to any of the tested particles clearly de-
creased cell viability, with the strongest effect observed for the Ti-15Zr-
15Mo wear particles.
For the more logistically complicated tests with HOb cells, a subset
of values for particle concentrations and experimental time points was
chosen, informed by the results obtained in the more comprehensive
tests with MG-63 cells and previous values reported in the literature
(Hallab et al., 2001). Compared to the untreated controls, only ex-
posure to the wear particles significantly decreased the viability of HOb
cells, with the strongest effect obtained for the Ti-6Al-4V wear particles
(Fig. 6). Complementary evidence from TEM images strongly indicated
that upon exposure at 50 μg/mL concentration, both Ti-6Al-4V and Ti-
15Zr-15Mo wear particles could be internalized by HOb cells (Fig. 7).
Specifically, the observed interaction between particles and the HOb
cell membrane indicated the beginning of the internalization process in
Fig. 7C and E; already internalized particles can be clearly observed in
Fig. 7D and F. The identification of the normal cell structures, such as
well-defined cell membrane and nucleus, was confirmed by comparison
to the images of the untreated controls (Fig. 7A and B), while the dif-
ference between the dark features in the untreated cells and the ones
identified as wear particles in Fig. 7C–F was verified by EDS (data not
shown).
3.5. Effects of exposure to Ti-based particles on cytokine production
The production of two important proinflammatory cytokines, IL-6
and PGE2, by HOb cells was evaluated by ELISA as a function of ex-
posure to commercial Ti-6Al-4V particles and wear particles of Ti-6Al-
4V or Ti-15Zr-15Mo (Fig. 8). Major differences were observed as a
function of multiple parameters. For IL-6 production, only the exposure
to wear particles for 7 days produced a significant increase compared to
the untreated control. A similar IL-6 increase in the endotoxin-exposed
controls validated the importance of using endotoxin-free particles in
these tests. The PGE2 production exhibited a different pattern, but ul-
timately became elevated after exposure for 3 days to the highest
concentration of both wear particles. The lack of increase in production
of either IL-6 or PGE2 upon exposure to the commercial Ti-6Al-4V
particles was another notable result of these experiments, highlighting
Table 1
Composition of Ti-6Al-4V and Ti-15Zr-15Mo alloys determined by EDS.
Sample Alloying Elements (wt%)
Ti Al V Zr Mo
Ti-6Al-4V 89.6 ± 0.5 6.4 ± 0.3 4.4 ± 0.6 - -
Ti-15Zr-15Mo 68.5 ± 0.2 - - 15.8 ± 0.2 15.7 ± 0.1
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the critical role of matching not only the crystal structure and compo-
sition but also the size and morphology of the wear particles that may
be generated in vivo.
4. Discussion
Fundamental differences were found in crystal structure and mi-
crostructure of Ti-alloys used in tribological tests for wear particle
production (Fig. 1). These differences may be attributed to type and
number of alloying elements introduced into titanium. Considering the
most established Ti-alloy for biomedical purposes, Ti-6Al-4V, the al-
loying elements aluminum and vanadium were originally introduced
into the titanium matrix to improve production costs and mechanical
properties when compared to cp-Ti (Cordeiro and Barão, 2017). For the
recently proposed Ti-alloys, such as Ti-15Zr-15Mo, it has been reported
that the addition of high amounts (≥15wt%) of β-stabilizing elements,
such as molybdenum, allows to obtain a decreased Young's modulus
(75 GPa) (Correa et al., 2014) and increased microhardness (400 HV)
(Xavier et al., 2017), making these alloys more suitable for bone sub-
stitute implants than Ti-6Al-4V (Young's modulus≈ 110 GPa (Chen and
Thouas, 2015) and microhardness≈ 330 HV (Rocha et al., 2006)).
Usually, harder alloys have higher wear resistance than softer ones
(Hacisalihoglu et al., 2015; Perumal et al., 2014). However, the amount
of obtained wear particles from tribological tests performed in identical
conditions was much higher on Ti-15Zr-15Mo system when compared
to Ti-6Al-4V, even though Ti-15Zr-15Mo has a higher measured mi-
crohardness value, suggesting that different wear mechanisms are
acting on these two Ti-alloys. Thus, besides differences in terms of
quantity, the obtained wear particles could also exhibit different
physicochemical properties.
Both types of wear particles (Ti-6Al-4V and Ti-15Zr-15Mo) ex-
hibited an irregular morphology and rougher surfaces than did Ti-6Al-
4V commercial particles (Fig. 2). These different characteristics may be
attributed to their generation mechanism by the sliding process over
the parent material during tribological tests. When sliding starts, the
surface of the alloys is readily worn out, literally ripping out small
particles with irregular shapes and surfaces. Therefore, in this process,
it is impossible to control or predict the amount, morphology, and
surface characteristics for the generated wear products.
The sizes of Ti-6Al-4V wear particles were, on average, 10 times
smaller than those of Ti-6Al-4V commercial particles, while Ti-15Zr-
15Mo wear particles were approximately twice and 30 times smaller
than Ti-6Al-4V wear particles and Ti-6Al-4V commercial particles, re-
spectively (Fig. 3). Considering the differences in bulk mechanical
properties and wear mechanisms acting on both titanium alloys during
tribological tests and the higher amount of particles produced by Ti-
15Zr-15Mo, it is very likely that the earlier produced wear particles left
on the worn area interfere in the way that the counter-body further
interact with the metal surface, possibly magnifying the wear effects,
releasing more particles or fracturing the existing ones (Oliveira et al.,
2015).
Regarding physicochemical properties, Ti-6Al-4V and Ti-15Zr-15Mo
wear particles were able to maintain the characteristics of the parent
material, both in terms of crystal structure (Fig. 4) and chemical com-
position (Table 1), indicating that, even when these materials are
submitted to stressful tribological testing conditions, these bulk char-
acteristics are not altered.
Several studies involving different types of implant-derived wear
Fig. 2. Size and morphology of Ti-based particles used in experiments with cells. Representative SEM images of commercial Ti-6Al-4V particles (A and B) and of wear
particles of Ti-6Al-4V (C and D) and Ti-15Zr15Mo (E and F) produced in tribological experiments.
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products (ions/particles) and their biological effects on living cells have
been conducted recently (Alves et al., 2013, 2015; Amanatullah et al.,
2016; Bitar and Parvizi, 2015; Cvijović-Alagić et al., 2016; Konttinen
and Pajarinen, 2013; Ribeiro et al., 2016; Sukur et al., 2016;
Vasconcelos et al., 2016). Previously, Hallab et al. (2001) already stu-
died the metal concentrations in blood serum and implant-surrounding
tissues after revision surgeries in human patients with orthopedic de-
vices based on Ti-6Al-4V alloy (and others). According to their results,
titanium (Ti) concentrations about 20% and 60% higher (part per bil-
lion, ppb or ng/mL) were found in the blood of patients with Ti-6Al-4V
total knee and hip replacements, respectively, and properly func-
tioning, compared to patients without metallic prosthesis. For patients
whose total knee and hip replacements were presenting malfunctioning
and/or needing revision, titanium concentrations may actually go up to
200% and 5000%, respectively. Besides that, in joint capsules, Ti con-
centrations may be more than 2 and 250 times higher in patients with
Fig. 3. Particle size distributions determined from SEM images of commercial
Ti-6Al-4V particles (A) and wear particles of Ti-6Al-4V (B) and Ti-15Zr-15Mo
(C) alloys.
Fig. 4. Crystal structure of Ti-based particles used in experiments with cells.
XRD wide-angle scan for commercial Ti-6Al-4V particles (A) and ED patterns
for wear particles of Ti-6Al-4V (B) and Ti-15Zr-15Mo (C) alloys.
Fig. 5. Viability of MG-63 cells as a function of exposure to commercial Ti-6Al-
4V particles and wear particles of Ti-6Al-4V or Ti-15Zr-15Mo. The untreated
control cells were cultured in the same medium but without added particles.
Asterisk indicates a statistically significant difference from the corresponding
control, p < 0.05. Particle concentrations are indicated on the bottom axis;
grey-scale of the bars corresponds to the duration of exposure. Absorbance
values in MTT assays are positively correlated with the number and mi-
tochondrial activity of viable cells in the sample.
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prosthetic devices working properly and malfunctioning, respectively,
when compared with prosthetic-free patients. Finally, considering
living organs, such as spleen and liver, Ti concentrations may be almost
18 and 80-fold higher (Hallab et al., 2001). These findings indicate a
chronic and continuous exposure to metallic compounds (such as tita-
nium) derived from prosthetic devices to the patients' organism.
As previously mentioned, wear particles also may trigger increased
production of proinflammatory cytokines by different cells in vivo, ac-
tivating osteoclasts, increasing bone resorption by osteolysis, leading to
different adverse tissue reactions, such as metallosis, particle disease
and, ultimately, the implant loosening (Amanatullah et al., 2016; Bitar
and Parvizi, 2015; Hallab and Jacobs, 2017; Landgraeber et al., 2014;
Sukur et al., 2016; Veronesi et al., 2017). Important aspects addressed
in these studies are the physicochemical characteristics of the wear
particles used, such as, size, morphology, and chemical composition,
which will strongly influence their biological fate inside a living or-
ganism (Madejczyk et al., 2015; Ribeiro et al., 2016; Sansone et al.,
2013; Vasconcelos et al., 2016; Zhang et al., 2017).
Most of the published papers, however, report physicochemical
properties and biological effects associated with cobalt-chromium,
polyethylene (Afolaranmi et al., 2012; Hongtao et al., 2011; Horev-
Azaria et al., 2011; Kwon et al., 2009; Papageorgiou et al., 2008;
Pourzal et al., 2011; Sansone et al., 2013; Wang et al., 2010), and
commercially available pure titanium-based wear particles, mainly re-
garding immune-system cells (macrophages) (Haleem-Smith et al.,
2012; Lee et al., 2012; Mostardi et al., 2010; Soto-Alvaredo et al., 2014;
Wu et al., 2008), wherein commercial particles are commonly used to
Fig. 6. Viability of HOb cells as a function of exposure to commercial Ti-6Al-4V
particles and wear particles of Ti-6Al-4V or Ti-15Zr-15Mo. The untreated
control cells were cultured in the same medium but without added particles.
Asterisk indicates a statistically significant difference from the corresponding
control, p < 0.05.
Fig. 7. Ultra-microstructure of HOb cells exposed to Ti-based wear particles. TEM images of the untreated controls (A and B) show well defined and preserved
cellular structures. Interacting and internalized wear particles of Ti-6Al-4V, respectively, are indicated in (C) and (D), of Ti-15Zr-15Mo—in (E) and (F).
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mimic chemical composition of wear particles. Nevertheless, commer-
cially available particles have controlled sizes and morphologies, sig-
nificantly differing from what we observed for the wear particles de-
rived from tribological tests as well as for biological effects associated
with them and evaluated in the present work (Figs. 5, Figs. 6 and 7).
Another important issue commonly not considered in the literature,
is the presence of organic molecules derived from the outer membrane
of Gram-negative bacteria, known as endotoxins or lipopolysaccharides
(LPS), adsorbed onto the particles. However, since these molecules may
trigger effects similar to those associated with wear particles in vivo,
namely the increased proinflammatory cytokine production, they
should be considered before carrying out assays with cells. According to
the LAL gel-clot assays performed in this work, all particles used in the
subsequent cell experiments may be considered endotoxin-free.
In our cell experiments (Figs. 5, Figs. 6 and 7), we noticed that Ti-
6Al-4V commercial particles did not exert strong negative effects on the
viability of human osteoblasts, irrespective of the exposure time, par-
ticle concentration, or cell line. On the other hand, the exposure to Ti-
6Al-4V wear particles (despite their very similar chemical composition)
or to Ti-15Zr-15Mo wear particles was able to decrease viability of both
MG-63 and HOb cells, for all experimental periods and tested con-
centrations. Furthermore, both types of wear particles were susceptible
to internalization by penetrating across HOb cell membranes, at con-
centration of 50 μg/mL.
Summarizing the above-mentioned findings, it is possible to con-
clude that (i) considering other physicochemical properties besides
chemical composition is extremely important when studying biological
effects associated with wear particles; (ii) their improved mechanical
properties when compared to Ti-6Al-4V notwithstanding, biological
effects associated with wear particles generated from new aluminum-
and vanadium-free Ti-alloys should be carefully investigated; and (iii)
not only nanoparticles are susceptible to internalization by living cells,
but also those at the microscale, probably due to the ions and proteins
adsorption around them, masking their real composition by creating a
bio-corona. Once internalized, both micro- and nanosized particles may
affect both metabolism of cells and organelles and their protein pro-
duction (Monopoli et al., 2011; Pederzoli et al., 2017).
Significant differences between results obtained for commercial
particles and wear particles were also recorded regarding the evalua-
tion of proinflammatory cytokine production (Fig. 8). Endotoxin-free
wear particles are noticeably more liable to induce increased cytokine
production, namely IL-6 and PGE2, by HOb cells than are endotoxin-
free commercial Ti-6Al-4V particles. The latter presented similar or
lower levels of IL-6 and PGE2 production when compared to the posi-
tive control, indicating that proinflammatory cytokine production was
not promoted by the interaction between the HOb cells and the com-
mercial particles. On the other hand, wear particles of both chemical
compositions induced an increased production for both IL-6 and PGE2
by these cells, indicating once more that not only the chemical com-
position appears to have a strong influence on the way these particles
interact with cells, since particles with same compositions but different
sizes and morphologies, such as Ti-6Al-4V commercial and wear par-
ticles, produced different impacts, probably because the increased ion
release rate due to reduced size and/or internalization effect of the wear
particles were able to enhance their negative effects. Furthermore,
these results also emphasize that both endotoxin-free wear particles and
endotoxin positive controls are able to induce increased production of
proinflammatory cytokines by osteoblasts, highlighting that endotoxins
must not be overlooked in studies of the particle effects.
Taking together the MTT (Fig. 6) and ELISA (Fig. 8) results, an al-
ternative understanding regarding the effects of Ti-based wear particles
exposure to human osteoblasts also may be hypothesized. In this work,
HOb cell viability was assessed by MTT assays, wherein the cell mi-
tochondrial activity is estimated by absorbance readings of MTT con-
version into its formazan product (Kumar et al., 2018). Accordingly, the
lower the absorbance reading is correlated with the lower mitochon-
drial activity, and consequently, the lower cell viability. However,
during differentiation processes, osteoblasts may also reduce their
aerobic energetic metabolism, and consequently their mitochondrial
activity, increasing the expression of specific markers, such as the in-
terleukin-6 (IL-6) production (Peruzzi et al., 2012). Since we verified
lower absorbance readings (decreased cell viability) in MTT assays
(Fig. 6) and an increased production of IL-6 by HOb cells exposed to Ti-
6Al-4V and Ti-15Zr-15Mo wear particles (Fig. 8), mainly at con-
centration of 50 μg/mL, it is also possible that the interaction of both
types of wear particles with the human osteoblasts may have induced
their differentiation, as previously reported by others (Bezerra et al.,
2017; Fernandes et al., 2018; Rossi et al., 2017).
5. Conclusion
Based on the obtained results, we are able to state that tribologi-
cally-obtained Ti-based wear particles (Ti-6Al-4V and Ti-15Zr-15Mo)
are significantly different from the commercial ones (Ti-6Al-4V),
mainly in terms of sizes (smaller) and morphology (irregular shapes and
rough surfaces), such differences being associated with the wear me-
chanisms acting on the parent materials during tribological tests.
Consequently, due to their different physicochemical properties, Ti-6Al-
4V and Ti-15Zr-15Mo wear particles also exert different influences on
human osteoblasts: more pronounced effects on decreasing cell viability
and/or metabolism and on increasing the proinflammatory cytokine
production by these cells when compared to the effects of commercial
Ti-6Al-4V particles. Ti-based wear particles also exhibited capability to
penetrate osteoblast cell membranes and to become internalized. In
general, the observed differences between wear particles and com-
mercial particles regarding their biological effects on human osteoblasts
may be attributed to the reduced size and increased ion release rate
Fig. 8. Cytokine production by HOb cells as a function of exposure to com-
mercial Ti-6Al-4V particles and wear particles of Ti-6Al-4V or Ti-15Zr-15Mo.
ELISA results are shown for (A) interleukin 6 (IL-6) and (B) prostaglandin E2
(PGE2). The untreated control cells were cultured in the same medium but
without added particles. The endotoxin (LPS) controls were exposed to 500 or
1000 EU/mL of endotoxin. Asterisk indicates a statistically significant differ-
ence from the corresponding untreated control, p < 0.05.
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associated with Ti-6Al-4V and Ti-15Zr-15Mo wear particles, high-
lighting the importance of considering other characteristics besides
chemical composition (the only characteristic commonly mimicked by
model particles used in most published studies). Finally, the importance
of removing adsorbed endotoxins in studies evaluating biological ef-
fects associated with wear particles was also demonstrated.
Funding
This work was supported by Fundação de Amparo à Pesquisa do
Estado de São Paulo - FAPESP (2015/50280-5 and 2017/24300-4),
Fundação para a Ciência e Tecnologia - FCT (UID/EEA/04436/2013),
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
(Finance Code 0001), FCT/CAPES Joint Research Project
(99999.008666/2014-08), FCT COMPETE 2020 (POCI-01-0145-
FEDER-006941 and POCI-01–0145-FEDER-007265) and M-ERA-NET
(0001/2015).
Acknowledgements
The authors thank Professor Carlos Roberto Grandini and MSc. Caio
Castanho Xavier for Ti-15Zr-15Mo samples and Dr. Vânia Villas Bôas
(INL) for her inestimable help in planning biological tests.
References
Afolaranmi, G.A., Akbar, M., Brewer, J., Grant, M.H., 2012. Distribution of metal released
from cobalt-chromium alloy orthopaedic wear particles implanted into air pouches in
mice. J. Biomed. Mater. Res. 100A, 1529–1538.
Alves, A.C., Oliveira, F., Wenger, F., Ponthiaux, P., Celis, J.P., Rocha, L.A., 2013.
Tribocorrosion behaviour of anodic treated titanium surfaces intended for dental
implants. J. Phys. D Appl. Phys. 46, 404001.
Alves, S.A., Saénz, R.B.V., Garcia, D.V.M.P., Igartua, A., Fernandes, M.H., Rocha, L.A.,
2015. Tribocorrosion behavior of calcium- and phosphorous-enriched titanium oxide
films and study of osteoblast interactions for dental implants. Bio. Tribo. Corros. 1,
1–21.
Amanatullah, D.F., Sucher, M.G., Bonadurer, G.F., Pereira, G.C., Taunton, M.J., 2016.
Metal in total hip arthroplasty: wear particles, biology, and diagnosis. Orthopedics
39, 371–379.
Bezerra, F., Ferreira, M.R., Fontes, G.N., Fernandes, C.J.C., Andia, D.C., Cruz, N.C., Silva,
R.A., Zambuzzi, W.F., 2017. Nano hydroxyapatite‐blasted titanium surface affects
pre‐osteoblast morphology by modulating critical intracellular pathways. Biotechnol.
Bioeng. 114, 1888–1898.
Bitar, D., Parvizi, J., 2015. Biological response to prosthetic debris. World J. Orthoped. 6,
172–189.
Chen, Q., Thouas, G.A., 2015. Metallic implant biomaterials. Mater. Sci. Eng. R Rep. 87,
1–57.
Cordeiro, J.M., Barão, V.A.R., 2017. Is there scientific evidence favoring the substitution
of commercially pure titanium with titanium alloys for the manufacture of dental
implants? Mater. Sci. Eng. C 71, 1201–1215.
Correa, D.R.N., Kuroda, P.A.B., Grandini, C.R., 2014. Structure, microstructure and se-
lected mechanical properties of Ti-Zr-Mo alloys for biomedical applications. Adv.
Mater. Res. 922, 75–80.
Correa, D.R.N., Kuroda, P.A.B., Grandini, C.R., Rocha, L.A., Oliveira, F.G.M., Alves, A.C.,
Toptan, F., 2016. Tribocorrosion behavior of β-type Ti-15Zr-based alloys. Mater. Lett.
179, 118–121.
Correa, D.R.N., Vicente, F.B., Araujo, R.O., Lourenço, M.L., Kuroda, P.A.B., Buzalaf,
M.A.R., Grandini, C.R., 2015. Effect of the substitutional elements on the micro-
structure of the Ti-15Mo-Zr and Ti-15Zr-Mo systems alloys. J. Mater. Res. Technol. 4,
180–185.
Cvijović-Alagić, I., Cvijović, Z., Bajat, J., Rakin, M., 2016. Electrochemical behaviour of
Ti-6Al-4V alloy with different microstructures in a simulated bio-environment.
Mater. Corros. 67, 1075–1087.
Fernandes, C.J.C., Bezerra, F., Ferreira, M.R., Andrade, A.F.C., Pinto, T.S., Zambuzzi,
W.F., 2018. Nano hydroxyapatite-blasted titanium surface creates a biointerface able
to govern Src-dependent osteoblast metabolism as prerequisite to ECM remodeling.
Colloids Surf. B Biointerfaces 163, 321–328.
Geetha, M., Singh, A.K., Asokamani, R., Gogia, A.K., 2009. Ti based biomaterials, the
ultimate choice for orthopaedic implants - a review. Prog. Mater. Sci. 54, 397–425.
Gepreel, M.A.-H., Niinomi, M., 2013. Biocompatibility of Ti-alloys for long-term im-
plantation. J. Mech. Behav. Biomed. Mater. 20, 407–415.
Hacisalihoglu, I., Samancioglu, A., Yildiz, F., Purcek, G., Alsaran, A., 2015. Tribocorrosion
properties of different type titanium alloys in simulated body fluid. Wear 332–333,
679–686.
Haleem-Smith, H., Argintar, E., Bush, C., Hampton, D., Postma, W.F., Chen, F.H.,
Rimington, T., Lamb, J., Tuan, R.S., 2012. Biological responses of human mesench-
ymal stem cells to titanium wear debris particles. J. Orthop. Res. 30, 853–863.
Hallab, N.J., Jacobs, J.J., 2017. Chemokines associated with pathologic responses to
orthopedic implant debris. Front. Endocrinol. (Lausanne). 8, 1–10.
Hallab, N.J., Mikecz, K., Vermes, C., Skipor, A., Jacobs, J.J., 2001. Orthopaedic implant
related metal toxicity in terms of human lymphocyte reactivity to metal-protein
complexes produced from cobalt-base and titanium-base implant alloy degradation.
Mol. Cell. Biochem. 222, 127–136.
Hongtao, L., Shirong, G., Shoufan, C., Shibo, W., 2011. Comparison of wear debris gen-
erated from ultra high molecular weight polyethylene in vivo and in artificial joint
simulator. Wear 271, 647–652.
Horev-Azaria, L., Kirkpatrick, C.J., Korenstein, R., Marche, P.N., Maimon, O., Ponti, J.,
Romano, R., Rossi, F., Golla-Schindler, U., Sommer, D., Uboldi, C., Unger, R.E.,
Villiers, C., 2011. Predictive toxicology of cobalt nanoparticles and ions: comparative
in vitro study of different cellular models using methods of knowledge discovery from
data. Toxicol. Sci. 122, 489–501.
Konttinen, Y.T., Pajarinen, J., 2013. Adverse reactions to metal-on-metal implants. Nat.
Rev. Rheumatol. 9, 5–6.
Kumar, P., Nagarajan, A., Uchil, P.D., 2018. Analysis of cell viability by the MTT assay.
Cold Spring Harb. Protoc. 2018 (6). https://doi.org/10.1101/pdb.prot095505.
Kwon, Y.-M., Xia, Z., Glyn-Jones, S., Beard, D., Gill, H.S., Murray, D.W., 2009. Dose-
dependent cytotoxicity of clinically relevant cobalt nanoparticles and ions on mac-
rophages in vitro. Biomed. Mater. 4, 025018.
Landgraeber, S., Jäger, M., Jacobs, J.J., Hallab, N.J., 2014. The pathology of orthopedic
implant failure is mediated by innate immune system cytokines. Mediat. Inflamm.
185150.
Lee, S.-S., Sharma, A.R., Choi, B.-S., Jung, J.-S., Chang, J.-D., Park, S., Salvati, E.A.,
Purdue, E.P., Song, D.-K., Nam, J.-S., 2012. The effect of TNF-alpha secreted from
macrophages activated by titanium particles on osteogenic activity regulated by
WNT/BMP signaling in osteoprogenitor cells. Biomaterials 33, 4251–4263.
Li, X., Liu, W., Sun, L., Aifantis, K.E., Yu, B., Fan, Y., Feng, Q., Cui, F., Watari, F., 2014.
Effects of physicochemical properties of nanomaterials on their toxicity. J. Biomed.
Mater. Res. A 103, 2499–2507.
Li, Y., Boraschi, D., 2016. Endotoxin contamination: a key element in the interpretation of
nanosafety studies. Nanomedicine 11, 269–287.
Madejczyk, M.S., Baer, C.E., Dennis, W.E., Minarchick, V.C., Leonard, S.S., Jackson, D.A.,
Stallings, J.D., Lewis, J.A., 2015. Temporal changes in rat liver gene expression after
acute cadmium and chromium exposure. PLoS One 10, 1–27.
Magalhães, P.O., Lopes, A.M., Mazzola, P.G., Rangel-Yagui, C., Penna, T.C., Pessoa Jr, A.,
2007. Methods of endotoxin removal from biological preparations: a review. J.
Pharm. Pharm. Sci. 10, 388–404.
Mathew, M.T., Srinivasa Pai, P., Pourzal, R., Fischer, A., Wimmer, M.A., 2009.
Significance of tribocorrosion in biomedical applications: overview and current
status. Adv. Tribol. 2009https://doi.org/10.1155/2009/250986. 250986.
McIntyre, C.A., Reinin, G., 2009. Reduction in endotoxin levels after performing the
prepare for aseptic sort procedure on the BD FACSAria II flow cytometer. BD Biosci.
Appl. Note 12.
Monopoli, M.P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F.,
Dawson, K.A., 2011. Physical-Chemical aspects of protein corona: relevance to in
vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133,
2525–2534.
Mostardi, R.A., Kovacik, M.W., Ramsier, R.D., Bender, E.T., Finefrock, J.M., Bear, T.F.,
Askew, M.J., 2010. A comparison of the effects of prosthetic and commercially pure
metals on retrieved human fibroblasts: the role of surface elemental composition.
Acta Biomater. 6, 702–707.
Niinomi, M., Nakai, M., Hieda, J., 2012. Development of new metallic alloys for bio-
medical applications. Acta Biomater. 8, 3888–3903.
Oliveira, C.A., Candelária, I.S., Oliveira, P.B., Figueiredo, A., Caseiro-Alves, F., 2015.
Metallosis: a diagnosis not only in patients with metal-on-metal prostheses. Eur. J.
Radiol. 2, 3–6.
Oliveira, F.G., Ribeiro, A.R., Perez, G., Archanjo, B.S., Gouvea, C.P., Araújo, J.R., Campos,
A.P.C., Kuznetsov, A., Almeida, C.M., Maru, M.M., Achete, C.A., Ponthiaux, P., Celis,
J.P., Rocha, L.A., 2015. Understanding growth mechanisms and tribocorrosion be-
haviour of porous TiO2 anodic films containing calcium, phosphorous and magne-
sium. Appl. Surf. Sci. 341, 1–12.
Papageorgiou, I., Shadrick, V., Davis, S., Hails, L., Schins, R., Newson, R., Fisher, J.,
Ingham, E., Case, C.P., 2008. Macrophages detoxify the genotoxic and cytotoxic ef-
fects of surgical cobalt chrome alloy particles but not quartz particles on human cells
in vitro. Mutat. Res. Fund Mol. Mech. Mutagen 643, 11–19.
Pederzoli, F., Tosi, G., Vandelli, M.A., Belletti, D., Forni, F., Ruozi, B., 2017. Protein
corona and nanoparticles: how can we investigate on? Wiley Interdiscip. Rev.
Nanomedicine Nanobiotechnology 9, e1467.
Perumal, G., Geetha, M., Asokamani, R., Alagumurthi, N., 2014. Wear studies on plasma
sprayed Al2O3-40 wt% 8YSZ composite ceramic coating on Ti-6Al-4V alloy used for
biomedical applications. Wear 311, 101–113.
Peruzzi, B., Cappariello, A., Del Fattore, A., Rucci, N., De Benedetti, F., Teti, A., 2012. C-
Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling. Nat.
Commun. 3, 610–630.
Ponthiaux, P., Wenger, F., Celis, J., 2012. Tribocorrosion : material behavior under
combined conditions of corrosion and mechanical loading. In: Corrosion Resistance,
pp. 81–106.
Pourzal, R., Catelas, I., Theissmann, R., Kaddick, C., Fischer, A., 2011. Characterization of
wear particles generated from CoCrMo alloy under sliding wear conditions. Wear
271, 1658–1666.
Ribeiro, A.R., Gemini-Piperni, S., Travassos, R., Lemgruber, L., Silva, R.C., Rossi, A.L.,
Farina, M., Anselme, K., Shokuhfar, T., Shahbazian-Yassar, R., Borojevic, R., Rocha,
L.A., Werckmann, J., Granjeiro, J.M., 2016. Trojan-like internalization of anatase
titanium dioxide nanoparticles by human osteoblast cells. Sci. Rep. 6, 23615.
Rocha, S.S., Adabo, G.L., Henriques, G.E.P., Nóbilo, M.A.A., 2006. Vickers hardness of
B.C. Costa, et al. Journal of the Mechanical Behavior of Biomedical Materials 95 (2019) 143–152
151
cast commercially pure titanium and Ti-6Al-4V alloy submitted to heat treatments.
Braz. Dent. J. 17, 126–129.
Rossi, M.C., Bezerra, F.J.B., Silva, R.A., Crulhas, B.P., Fernandes, C.J.C., Nascimento, A.S.,
Pedrosa, V.A., Padilha, P., Zambuzzi, W.F., 2017. Titanium-released from dental
implant enhances pre-osteoblast adhesion by ROS modulating crucial intracellular
pathways. J. Biomed. Mater. Res. 105 (Part A), 2968–2976.
Sansone, V., Pagani, D., Melato, M., 2013. The effects on bone cells of metal ions released
from orthopaedic implants. A review. Clin. Cases Miner. Bone Metab. 10, 34–40.
Soto-Alvaredo, J., Blanco, E., Bettmer, J., Hevia, D., Sainz, R.M., López Chavés, C.,
Sánchez, C., Llopis, J., Sanz-Medel, A., Montes-Bayón, M., 2014. Evaluation of the
biological effect of Ti generated debris from metal implants: ions and nanoparticles.
Metallomics 6, 1702–1708.
Sukur, E., Akman, Y.E., Ozturkmen, Y., Kucukdurmaz, F., 2016. Particle Disease: a current
review of the biological mechanisms in periprosthetic osteolysis after hip ar-
throplasty. Open Orthop. J. 10, 241–251.
Sundell, G., Dahlin, C., Andersson, M., Thuvander, M., 2017. The bone-implant interface
of dental implants in humans on the atomic scale. Acta Biomater. 48, 445–450.
Vasconcelos, D.M., Santos, S.G., Lamghari, M., Barbosa, M.A., 2016. The two faces of
metal ions: from implants rejection to tissue repair/regeneration. Biomaterials 84,
262–275.
Veronesi, F., Tschon, M., Fini, M., 2017. Gene expression in osteolysis: review on the
identification of altered molecular pathways in preclinical and clinical studies. Int. J.
Mol. Sci. 18, 499–522.
Wang, S., Ge, S., Liu, H., Huang, X., 2010. Wear behaviour and wear debris character-
ization of UHMWPE on alumina ceramic, stainless steel, CoCrMo and Ti6Al4V hip
prostheses in a hip joint simulator. J. Biomimetics, Biomaterials Tissue Eng. 7, 7–25.
Wang, Z.B., Hu, H.X., Zheng, Y.G., Ke, W., Qiao, Y.X., 2016. Comparison of the corrosion
behavior of pure titanium and its alloys in fluoride-containing sulfuric acid. Corros.
Sci. 103, 50–65.
Watters, T.S., Cardona, D.M., Menon, K.S., Vinson, E.N., Bolognesi, M.P., Dodd, L.G.,
2010. Aseptic lymphocyte-dominated vasculitis-associated lesion: a clinicopathologic
review of an underrecognized cause of prosthetic failure. Am. J. Clin. Pathol. 134,
886–893.
Wu, J., Yin, G., Chen, H.-Q., Sung, K.-L.-P., 2008. The influence of titanium particles size
on bone marrow mensenchymal stem cells viability. Key Eng. Mater. 361–363 (II),
1063–1066.
Xavier, C.C., Correa, D.R.N., Grandini, C.R., Rocha, L.A., 2017. Low temperature heat
treatments on Ti-15Zr-xMo alloys. J. Alloy. Comp. 727, 246–253.
Zhang, D., Wong, C.S., Wen, C., Li, Y., 2017. Cellular responses of osteoblast-like cells to
17 elemental metals. J. Biomed. Mater. Res. A 105, 148–158.
B.C. Costa, et al. Journal of the Mechanical Behavior of Biomedical Materials 95 (2019) 143–152
152
